Jump to content
Sclero Forums
Sign in to follow this  
Guest Sherrill

Pamidronate Infusion In Patients With Systemic Sclerosis Results In Changes In Blood Mononuclear Cell Cytokine Profiles.

Recommended Posts

Guest Sherrill

Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.A single infusion of pamidronate was given to patients with systemic sclerosis (scleroderma, SSc) to assess effects on cytokine production by peripheral blood mononuclear cells (PBMC) and lymphocyte subsets. The effects of pamidronate on modulation of cytokine profiles in patients with SSc may merit future study. PubMed. Clin Exp Immunol. 2006 Dec;146(3):371-80. (Also see: Scleroderma Treatments and Causes of Scleroderma: Cytokines)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information. http://www.sclero.org/news/a-to-z.html

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×